San Donato Hospital
Obesity treatment cost in Italy typically starts with a bariatric surgery consultation ranging from $200 to $300. Primary surgical interventions like gastric sleeve surgery run from $12,500 to $20,000, while gastric bypass costs between $10,500 and $12,900. Total expenses depend on the surgical technique, BMI class, and hospital stay duration. Patients can find top-tier treatment centers primarily in Milan and Rome.
Typical Obesity Treatment Costs in Italy
Bookimed Expert Insight: Patients seeking maximum precision should prioritize robotic options. IRCCS Ospedale Galeazzi - Sant'Ambrogio offers Da Vinci sleeve and bypass procedures starting around $30,600. For non-surgical needs, gastric balloon packages are available for approximately $6,200. High-volume surgeons like Dr. Antonio Braun, with 12,000+ operations, provide excellent value for complex gastrointestinal cases. Milan-based IRCCS centers are ideal for patients requiring multidisciplinary care and internationally recognized standards.
| Italy | Turkey | Austria | |
| Gastric sleeve surgery (Sleeve gastrectomy) | from $12,500 | from $3,200 | from $15,000 |
| Gastric bypass | from $10,544 | from $5,000 | from $13,000 |
| Gastric band | from $9,000 | from $4,275 | from $14,000 |
| Gastric balloon | from $3,500 | from $1,691 | from $5,000 |
| Endoscopic sleeve gastroplasty (ESG) | from $7,500 | from $2,840 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Obesity treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Obesity treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Obesity treatment journey.
Dr. Ayman specializes in minimally invasive bariatric surgery, performing over 1,000 surgeries annually at Maria Cecilia Hospital.
500+ successful Nissen and Toupet Fundoplications – Dr. Braun specializes in minimally invasive obesity surgery at Maria Cecilia Hospital.
Head of Gastrointestinal Surgery at San Raffaele – leads one of Italy's most recognized high-volume centers for esophageal surgery.
Italy is the first country globally to legally recognize obesity as a chronic, progressive, and relapsing disease. Under Law No. 149/2025, the Italian Senate shifted obesity from a lifestyle choice to a pathology. This legislation integrates obesity treatment into the National Health Service (SSN) framework.
Bookimed Expert Insight: While the 2025 law sets a global legal precedent, clinical expertise in Italy was already highly developed. IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan performs over 5,000 operations annually. Surgeons like Dr. Alessandro Giovanelli have completed over 9,000 procedures. This high volume ensures that legal recognition is backed by significant surgical experience and advanced technology like the da Vinci robot.
Patient Consensus: Patients note that while the law provides a framework, actual access to surgery under the public system requires meeting strict BMI thresholds. It remains essential to document all previous weight-loss attempts and comorbidities meticulously for insurance or health service approval.
Eligibility for bariatric surgery via the Italian National Health System requires a Body Mass Index of 40 or higher. Patients with a Body Mass Index of 35 may qualify if they have serious comorbidities. These conditions include type 2 diabetes, hypertension, or severe obstructive sleep apnea.
Bookimed Expert Insight: Italian centers of excellence show a clear preference for high-volume expertise. For example, Dr. Alessandro Giovanelli at IRCCS Ospedale Galeazzi - Sant'Ambrogio has performed over 9,000 operations. Choosing a surgeon with this volume often leads to better access to advanced technologies like the da Vinci robot, which is available in Milan and Rome clinics.
Patient Consensus: Patients note that meeting the strict BMI requirements is only the first step. Many emphasize that keeping detailed logs of past diets and exercise is essential to avoid application rejections.
In Italy, the Italian Medicines Agency (AIFA) authorizes semaglutide (Wegovy, Ozempic), liraglutide (Saxenda), and orlistat (Xenical) for weight management. Doctors prescribe these for patients with a BMI over 30. Specialists at clinics like San Raffaele in Milan also utilize naltrexone/bupropion (Mysimba) for appetite control.
Bookimed Expert Insight: While many patients seek GLP-1 injections, Italian medical centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio often integrate these with surgical consultations. Data shows that high-volume centers performing over 5,000 operations annually prioritize long-term metabolic health. This suggests that medications are increasingly used as a bridge to, or in combination with, procedures like intragastric balloons, which may cost around $6,050 in specialized Milanese clinics.
Patient Consensus: Patients note that while Saxenda is widely available through GPs, newer drugs like Wegovy often face supply shortages. Many find that private endocrinologist visits in Milan or Rome provide faster access to prescriptions than the public health system.
To start obesity treatment in Italy, obtain a medical referral from a primary care physician to access the National Health Service (SSN) framework. Patients typically undergo multidisciplinary screenings at accredited centers. Specialized facilities like IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan offer advanced robotic and laparoscopic surgical interventions.
Bookimed Expert Insight: Italian centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio provide high-tier surgical safety with specialists like Dr. Alessandro Giovanelli performing over 9,000 operations. Our data shows that top Milanese clinics often bundle language assistance and 3-4 days of hospitalization into surgical packages. This level of institutional experience is vital for complex revisions, as this specific hospital performs 75% of Italy's orthopedic revisions, signaling a strong culture of managing difficult cases.
Patient Consensus: Patients note that while the public system is affordable, waiting times can exceed 6 months, leading many to choose private care in Northern Italy for faster access. Many suggest keeping detailed records of your BMI and past weight loss attempts to speed up the surgical approval process.
Italy hosts nationally recognized centers for obesity treatment, primarily concentrated in Milan and Lombardy. Leading institutions include IRCCS Policlinico San Donato and IRCCS Ospedale Galeazzi-Sant’Ambrogio. These facilities hold IRCCS accreditation from the Italian Ministry of Health for excellence in clinical research and specialized bariatric care.
Bookimed Expert Insight: While hospital reputation is vital, our data shows a significant technology gap in mid-range packages. IRCCS Ospedale Galeazzi-Sant’Ambrogio offers robotic-assisted procedures for approximately $30,000, which is nearly $10,000 more than standard laparoscopic options. For patients with high BMI or previous abdominal surgeries, the robotic platform's precision may justify this investment to ensure smoother recovery.
Patient Consensus: Patients note that private care in Milan or Bologna significantly reduces waiting times compared to the 18-month national health service queues. Many recommend verifying if surgeons personally perform at least 100 cases annually to ensure the highest safety standards.